Detalles de la búsqueda
1.
The discovery and evaluation of [18F]BMS-986229, a novel macrocyclic peptide PET radioligand for the measurement of PD-L1 expression and in-vivo PD-L1 target engagement.
Eur J Nucl Med Mol Imaging
; 51(4): 978-990, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38049658
2.
Discovery of renin inhibitors containing a simple aspartate binding moiety that imparts reduced P450 inhibition.
Bioorg Med Chem Lett
; 27(21): 4838-4843, 2017 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28985999
3.
Development, Characterization, and Radiation Dosimetry Studies of 18F-BMS-986229, a 18F-Labeled PD-L1 Macrocyclic Peptide PET Tracer.
Mol Imaging Biol
; 26(2): 301-309, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38123744
4.
4-(Phenylaminomethylene)isoquinoline-1,3(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4 (CDK4).
J Med Chem
; 51(12): 3507-25, 2008 Jun 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-18494457
5.
Synthesis and Biologic Evaluation of a Novel 18F-Labeled Adnectin as a PET Radioligand for Imaging PD-L1 Expression.
J Nucl Med
; 59(3): 529-535, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29025984
6.
Discovery of 4-(benzylaminomethylene)isoquinoline-1,3-(2H,4H)-diones and 4-[(pyridylmethyl)aminomethylene]isoquinoline-1,3-(2H,4H)-diones as potent and selective inhibitors of the cyclin-dependent kinase 4.
J Med Chem
; 52(8): 2289-310, 2009 Apr 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-19317452
Resultados
1 -
6
de 6
1
Próxima >
>>